Dana-Farber Breast Cancer Program:
Enabling Critical Interventions
Our support advances critical breakthroughs such as:
- Optimize Metastatic Breast Cancer Clinical Trials by identifying biomarkers predicting treatment response.
- Leverage Large-Scale Data and Artificial Intelligence through AI algorithms will predict disease recurrence and treatment response.
- Use Liquid Diagnostics for Metastatic Breast Cancer to enable real-time treatment monitoring and develop interventions to prevent cancer recurrence.
- Offer annual internal awards for innovative metastatic breast cancer research.